Patents by Inventor George M. G. M. Verjans

George M. G. M. Verjans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HSV-1 epitopes and methods for using same
    Patent number: 9328144
    Abstract: The invention provides HSV antigens and epitopes that are useful for the prevention and treatment of HSV infection. T-cells having specificity for antigens of the invention have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity provides improved anti-viral therapeutic and prophylactic strategies. Compositions containing antigens or polynucleotides encoding antigens of the invention provide effectively targeted vaccines for prevention and treatment of HSV infection.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: May 3, 2016
    Assignees: UNIVERSITY OF WASHINGTON, Erasmus University Medical Center Rotterdam (Erasmus MC)
    Inventors: David M. Koelle, George M. G. M. Verjans